The injection is given intramuscularly, meaning it is injected into a muscle, usually in the upper arm or thigh
Clinically, we often observe that oral BPC-157 offers superior outcomes for patients with GI inflammation, bloating, food sensitivities, or irritable bowel symptoms
People with diabetes, muscular degeneration, Lou Gehrigs disease
Safety Considerations So far, BPC-157 has shown a strong safety profile in preclinical and limited human studies
G.KomaroffA
In MCAS, mast cells inappropriately release massive amounts of histamine and other inflammatory mediators, causing widespread allergic-type symptoms, brain fog, and gastrointestinal distress